<?xml version="1.0" encoding="UTF-8"?>
<p>Many methodologies have been proposed to deliver cost/effective diagnosis (i.e., those based on immunoassays or specific gene hybridization [
 <xref rid="pone.0215642.ref007" ref-type="bibr">7</xref>,
 <xref rid="pone.0215642.ref013" ref-type="bibr">13</xref>–
 <xref rid="pone.0215642.ref016" ref-type="bibr">16</xref>]); however, nucleic acid amplification continues to be the gold standard for the detection of viral diseases in early stages [
 <xref rid="pone.0215642.ref009" ref-type="bibr">9</xref>,
 <xref rid="pone.0215642.ref011" ref-type="bibr">11</xref>,
 <xref rid="pone.0215642.ref017" ref-type="bibr">17</xref>–
 <xref rid="pone.0215642.ref019" ref-type="bibr">19</xref>]. Among these, the polymerase chain reaction (PCR) is the most established method for molecular diagnostics [
 <xref rid="pone.0215642.ref010" ref-type="bibr">10</xref>,
 <xref rid="pone.0215642.ref020" ref-type="bibr">20</xref>]. However, bringing the benefits of PCR to remote or unprivileged areas has been challenging due to the need for centralized laboratory settings to accomplish traditional PCR testing [
 <xref rid="pone.0215642.ref021" ref-type="bibr">21</xref>–
 <xref rid="pone.0215642.ref023" ref-type="bibr">23</xref>], coupled with the still inherently high cost of traditional PCR equipment and reagents [
 <xref rid="pone.0215642.ref024" ref-type="bibr">24</xref>]. To resolve this drawback, multiple studies have proposed and validated the use of compact PCR-based methods and devices for POC settings [
 <xref rid="pone.0215642.ref022" ref-type="bibr">22</xref>,
 <xref rid="pone.0215642.ref025" ref-type="bibr">25</xref>,
 <xref rid="pone.0215642.ref026" ref-type="bibr">26</xref>].
</p>
